AGGF1P2

Across TCGA pan-cancer cohorts, AGGF1P2 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated AGGF1P2 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher AGGF1P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated AGGF1P2 expression acts as an unfavorable survival marker, although some lineages such as KIRP and UVM show a favorable association.

KIRC, KIRP, and ESCA are the cancer types where AGGF1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.549	0.699	<.001	70	view →
KIRP	DFS	Median	All	0.928	0.544	.001	60	view →
ESCA	DFS	Median	All	0.199	0.422	<.001	27	view →
UVM	OS	Quartile	II,III,IV	0.823	0.403	.009	25	view →
ACC	DFS	Tertile	All	0.312	0.817	.002	25	view →
LGG	DFS	Tertile	All	0.902	0.799	.002	19	view →
SARC	OS	Median	All	0.761	0.940	.001	17	view →
BRCA	OS	Quartile	All	0.982	0.952	.009	15	view →
LUSC	OS	Median	III,IV	0.554	0.916	.011	15	view →
MESO	OS	Median	III,IV	0.494	0.282	.001	14	view →
PAAD	OS	Quartile	All	0.589	0.246	.016	12	view →
SKCM	OS	Quartile	II,III,IV	0.811	0.636	.012	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

AGGF1P2–KIRC (OS)

Open the KIRC breakdown →